Source: Virtual Congress 2020 – From respiratory physiology to clinical practice: exercise and respiratory muscles
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Badal (Sydney, Australia), N. Reed (Sydney, Australia), L. Seccombe (Sydney, Australia), A. Cottee (Sydney, Australia), C. Thamrin (Sydney, Australia), G. King (Sydney, Australia), M. Peters (Sydney, Australia), C. Farah (Sydney, Australia). Improved small airway function by benralizumab in patients with severe eosinophilic asthma. 3215

Member's Comments

No comment yet.

Related content which might interest you: Mepolizumab improves small airway function in severe eosinophilic asthma Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions Year: 2018 Effects of formoterol-budesonide combination on residual eosinophilic inflammation in distal airway of patients with well-controlled moderate asthma Source: Annual Congress 2011 - Asthma management and response Year: 2011 Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Small airway impairment in severe asthmatic patients Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Rapid Benralizumab effectiveness in patients with severe eosinophilic asthma and bronchiectasis Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Parameters associated with persistent airflow obstruction in chronic severe asthma Source: Eur Respir J 2004; 24: 122-128 Year: 2004 Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Cell phenotyping, asthma control, and airway obstruction in severe asthma Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS Year: 2017 Mepolizumab improves activity limitation in severe eosinophilic asthma Source: International Congress 2017 – Notable abstracts in asthma Year: 2017 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Role of neutrophils in airway inflammation in children with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction Source: Eur Respir J 2002; 20: Suppl. 38, 505s Year: 2002 Diagnosis of small airways dysfunction in patients with asthma. Source: Virtual Congress 2020 – Lung function diagnostics Year: 2020 Small airways disease evaluation in patients with mild/moderate asthma and correlation with bronchial hyperresponsiveness and disease control Source: International Congress 2018 – Clinical and functional monitoring in airway disease Year: 2018 Characterisation of severe eosinophilic asthma patients who failed Mepolizumab therapy Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Fixed airway obstruction in patients with severe asthma Source: International Congress 2018 – Tests and trends in asthma Year: 2018 Predictors of exercise-induced airways obstruction in patients with mild asthma. Source: Virtual Congress 2020 – Exploring exercise responses in respiratory diseases Year: 2020 Factors driving airway eosinophilia in prednisone-dependent severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017